KKR Takes Taiyo Private in Strategic Bet on AI and Pharma Growth

TOKYO, Japan – March 31, 2026 – Global investment giant KKR has announced its intention to acquire and privatize Taiyo Holdings, a world leader in electronic materials, in a landmark deal poised to reshape the Japanese industrial landscape. The move, structured as a tender offer for all common shares, has received the full backing of Taiyo's board and key shareholders, setting the stage for a strategic shift designed to accelerate the company's ambitious growth plans in high-demand sectors like artificial intelligence and pharmaceuticals.

The acquisition will be managed by an entity owned by KKR's investment funds. It has already secured agreements from shareholders representing approximately 42.2% of Taiyo's outstanding shares, including its largest shareholder DIC Corporation, founding family affiliate Kowa Co., Ltd., and prominent investor Oasis Management Company Ltd. This broad support signals strong confidence in the privatization strategy as the optimal path forward for the venerable materials manufacturer.

A Strategic Pivot from Public Scrutiny

At the heart of the decision to go private is Taiyo Holdings' long-term management plan, “Beyond Imagination 2030.” The company's leadership concluded that the pressures of the public market, with its focus on quarterly earnings and short-term performance, were becoming a hindrance to the sustained, heavy investment required to capitalize on future technology waves. In recent years, Japanese regulators, including the Tokyo Stock Exchange, have increased pressure on public companies to improve returns and shareholder value, an environment that can stifle long-range strategic planning.

By delisting, Taiyo aims to gain the agility and stability needed to pursue its goals. The company is a dominant force in the global market for solder resist, a critical material for printed circuit boards (PCBs), holding over 50% of the market share. Its leadership sees immense opportunity in leveraging this core competency to serve the burgeoning needs of generative AI, data centers, and next-generation communications infrastructure, all of which demand increasingly sophisticated electronic components. As a private entity under KKR's stewardship, Taiyo can make bold, long-term bets on research and development without facing public market volatility.

"This strategic partnership with KKR marks an important milestone for Taiyo Holdings," said Hitoshi Saito, President and Chief Executive Officer of Taiyo Holdings, in a statement. "As a private company, we will be able to pursue long-term investments in our core technologies with greater focus and stability, which we could not achieve on our own." The move also aims to bolster the company's secondary business in medicine and pharmaceuticals, where it operates a growing contract manufacturing division, a market in Japan projected to double in value to over $26 billion by 2033.

The Financials of a Landmark Deal

The tender offer proposes a price of JPY 4,750 per common share, a figure that underscores the value KKR places on Taiyo's future potential. The price represents a staggering premium of 117.19% over the six-month average unaffected closing price as of May 27, 2025. While the offer reflects a slight discount to the stock's closing price on March 31, 2026, this is largely due to a significant run-up in the share price over the past year—a surge of over 114%—as market speculation about a potential deal mounted. The substantial premium over the unaffected historical price is a more accurate measure of the value being offered to long-term shareholders.

The unified front presented by major shareholders is a critical component of the deal's strength. The participation of industrial partner DIC Corporation, activist fund Oasis Management, and the Kowa Co., which is affiliated with Taiyo's founding family, demonstrates a rare consensus. This alignment was crucial in securing the deal. Further cementing the partnership, Taiyo's founding family plans to re-invest in the KKR-managed vehicle that will own the company, signaling a deep-seated belief in the new private structure and KKR's ability to drive growth.

KKR's Deepening Playbook in Japan

This acquisition is not an isolated event but a key move in KKR's well-established strategy in Japan. With two decades of investment history and over $20 billion in assets under management in the country, KKR has a track record of taking established Japanese industrial and technology companies private to unlock their potential. This investment in Taiyo is part of KKR’s flagship Asia Pacific private equity strategy and follows a pattern seen in its other major Japanese holdings.

KKR's portfolio includes KOKUSAI ELECTRIC, a leading semiconductor equipment supplier, and Bushu Pharma, a pharmaceutical contract development and manufacturing organization (CDMO). The experience with Bushu Pharma is particularly relevant, providing KKR with deep operational expertise in one of Taiyo’s key growth areas. By applying its global network and sector-specific knowledge, KKR aims to help Taiyo expand its reach and operational efficiency.

"We look forward to leveraging KKR’s global network and operational expertise in the advanced materials and pharmaceutical sectors to help Taiyo Holdings unlock future growth and greater value for its clients,” noted Eiji Yatagawa, Partner and Head of Japan Private Equity at KKR. This approach—combining patient capital with hands-on operational support—has become a hallmark of private equity's evolving role in Japan, often serving as a catalyst for corporate restructuring, modernization, and a solution to succession challenges in family-controlled businesses.

Navigating the Path to Privatization

While the agreement marks a significant step, the transaction is not yet complete. The tender offer is contingent upon satisfying customary conditions, including a series of regulatory approvals from Japanese authorities. Given Taiyo's strategic importance in the global electronics supply chain and its involvement in the pharmaceutical sector, the deal will likely undergo a thorough review.

Key government bodies, including the Japan Fair Trade Commission (JFTC) and the Ministry of Finance (MOF), will scrutinize the acquisition. Under Japan's Foreign Exchange and Foreign Trade Act (FEFTA), foreign investment in industries deemed critical to national security—a category that can include advanced materials and certain pharmaceuticals—requires prior notification and consent. This regulatory framework is designed to protect Japan's technological and industrial base, and the review process for a deal of this scale will be meticulous.

The transaction will also proceed under Japan's recently amended Financial Instruments and Exchange Law (FIEL), which has introduced stricter regulations for tender offers to enhance market fairness. Navigating this complex legal and regulatory landscape will be the next critical phase for KKR and Taiyo Holdings as they work to finalize a partnership that could set a new precedent for industrial growth in Japan.